06.01.2014 Views

Annual Report 2010 - Hannover Re

Annual Report 2010 - Hannover Re

Annual Report 2010 - Hannover Re

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Business development<br />

We are thoroughly satisfied with the development of our business<br />

in the year under review. Market conditions for financially<br />

strong reinsurers such as <strong>Hannover</strong> <strong>Re</strong> were good in<br />

both non-life and life/health reinsurance. Gross premium in<br />

total business grew to EUR 11.4 billion (EUR 10.3 billion). The<br />

operating profit (EBIT) climbed to EUR 1.2 billion (EUR 1.1<br />

billion), while the Group net income of EUR 748.9 million<br />

(EUR 733.7 million) surpassed both our forecast and the<br />

record profit reported in the previous year.<br />

Even though a trend towards softening reinsurance conditions<br />

could be observed in some non-life reinsurance markets, not<br />

all lines were affected in the same way. Overall, prices were<br />

still very much commensurate with the risks. The <strong>2010</strong> financial<br />

year was impacted by the large number of (natural) catastrophe<br />

losses; for our company too, the burden of major losses<br />

significantly exceeded our expectations. Nevertheless, these<br />

strains were offset by the otherwise good performance of our<br />

non-life reinsurance portfolio. For further details of developments<br />

in non-life reinsurance in the year under review please<br />

see page 21 et seq.<br />

Our second business group, life and health reinsurance, delivered<br />

particularly vigorous growth. Its contribution to the total<br />

premium volume now stands at 44.5%. Given the low volatility<br />

of results we have set ourselves premium growth targets<br />

here – unlike in non-life reinsurance. In the year under review<br />

we achieved in full not only these goals but also our profit<br />

targets. For detailed comments on the development of business<br />

in life and health reinsurance please see page 36 et seq.<br />

Gross premium by business group <br />

We are also highly satisfied with the development of our investments.<br />

Thanks to positive cash inflows from the technical<br />

account and improvements in fair values, our portfolio of assets<br />

under own management grew appreciably to EUR 25.4<br />

billion (EUR 22.5 billion). Despite the overall decline in interest<br />

rate levels ordinary income consequently surpassed the<br />

comparable figure for the previous year at EUR 880.5 million<br />

(EUR 810.5 million). Income on funds withheld and contract<br />

deposits climbed to EUR 316.4 million (EUR 276.8 million).<br />

The impairments of EUR 16.5 million taken on securities (excluding<br />

real estate) were considerably lower than in the previous<br />

year (EUR 141.3 million). Of this amount, EUR 7.7 million<br />

(EUR 92.6 million) was attributable to alternative investments<br />

– primarily private equity funds. Write-downs of just EUR 0.6<br />

million (EUR 3.2 million) had to be taken on equities, while on<br />

fixed-income assets they contracted sharply to EUR 7.9 million<br />

(EUR 45.4 million). In view of increased fair values, the writedowns<br />

were opposed by write-ups of EUR 24.1 million (EUR<br />

9.3 million) on fixed-income securities written down in previous<br />

periods as well as write-ups of EUR 3.0 million (EUR 10.8<br />

million) on alternative investments.<br />

The unrealised losses on our assets recognised at fair value<br />

through profit or loss amounted to EUR 39.9 million, as<br />

against unrealised gains of EUR 100.6 million in the previous<br />

year. The losses derived predominantly (EUR 31.2 million)<br />

from changes in the value of inflation swaps taken out to<br />

hedge inflation risks associated with the loss reserves in our<br />

technical account. Particularly in light of the attractive market<br />

environment for fixed-income securities, we realised amounts<br />

of altogether EUR 162.0 million (EUR 113.0 million). In the<br />

second half of the year we began to move back into listed<br />

equities; our equity allocation at year-end was 2.1%.<br />

Compared to the previous year, we were again able to boost<br />

our net investment income from assets under own management<br />

– it totalled EUR 942.5 million (EUR 843.6 million) in the<br />

financial year just-ended. Net investment income including<br />

income on funds withheld and contract deposits amounted to<br />

EUR 1.3 billion (EUR 1.1 billion).<br />

Management report<br />

44.5% Life and<br />

health reinsurance<br />

55.5% Non-life<br />

reinsurance<br />

Demand for reliable reinsurance protection remained strong<br />

in the year under review. Premium income consequently grew<br />

more vigorously than anticipated: gross premium in total business<br />

increased by 11.2% to EUR 11.4 billion (EUR 10.3 billion).<br />

At constant exchange rates – especially against the US<br />

dollar – growth would have come in at 6.8%. The level of retained<br />

premium retreated to 90.1% (92.6%). Net premium<br />

earned climbed 7.9% to EUR 10.0 billion (EUR 9.3 billion).<br />

Group net income for the year under review substantially exceeded<br />

our expectations. A very good profit on ordinary activities<br />

was assisted by a special effect associated with a decision<br />

of the Federal Fiscal Court (BFH) which had a bearing on<br />

our company. After the BFH had confirmed in its ruling of<br />

<strong>Hannover</strong> <strong>Re</strong> Group annual report <strong>2010</strong><br />

Business development Management report<br />

19

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!